| abstract |
Wherein the peptide hormone is a pharmaceutically active peptide hormone derivative modified by introducing a lipophilic substituent W to the N-terminal amino acid of the peptide hormone or analog thereof, or a lipophilic substituent Z to the C-terminal amino acid, A peptide hormone derivative having 8 to 40 carbon atoms as the substituent has a continuous action profile. |